Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2006; 131(28/29): 1615
DOI: 10.1055/s-2006-947808
DOI: 10.1055/s-2006-947808
Pro & Contra | Commentary
Dermatologie
© Georg Thieme Verlag KG Stuttgart · New York
Topische Calcineurin-Inhibitoren bei atopischem Ekzem - Contra
Topical calcineurin inhibitors in atopic eczema - contraFurther Information
Publication History
eingereicht: 13.3.2006
akzeptiert: 16.3.2006
Publication Date:
06 July 2006 (online)

Schlüsselwörter
Calcineurin-Inhibitoren - topische Immunmodulatoren - atopische Dermatitis
Key words
calcineurin inhibitors - topical immune modulators - atopic dermatitis
Literatur
- 1 Anonymous . Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough. Prescrire Int. 2004; 13 209-212
- 2 Becker J C, Houben R, Vetter C S, Bröker C S. The carcinogenic potential of tacrolimus beyond immune suppression: a hypothesis creating case report. BMC Cancer. 2006; 6 7
- 3 Garside R, Stein K, Castelnuovo E. et al . The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. Health Technol Assess. 2005; 9 1-230
- 4 Niedner R. Kortikoide in der Dermatologie. UniMed, Bremen. 1998; 63-64
- 5 Paller A S, Lebwohl M, Fleicher A B. et al . Tacrolimus ointment is more effective than pimecrolimus cream with a similar saftey profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol. 2005; 52 810-822
Prof. Dr. med. Dietrich Abeck
Hautzentrum Harlaching
Grünwalder Straße 248
81545 München
Email: Dietrich.Abeck@lrz.tu-muenchen.de